Search

Home > GRACEcast Lung Cancer Video > Can we predict which patients will benefit from Tarceva based on a blood test?
Podcast: GRACEcast Lung Cancer Video
Episode:

Can we predict which patients will benefit from Tarceva based on a blood test?
Category: Science & Medicine
Duration: 00:07:55
Publish Date: 2013-06-12 02:05:57
Description:

Drs. Mary Pinder, Nate Pennell, and Jack West review results from the PROSE trial presented at ASCO 2013, testing the predictive value of the Veristrat test of serum proteomics to assess the potential value of erlotinib (Tarceva) in advanced NSCLC.
Total Play: 0